SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030663
Filing Date
2024-08-08
Accepted
2024-08-08 07:25:30
Documents
90
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1094735
2 ex4-1.htm EX-4.1 95236
3 ex10-2.htm EX-10.2 20615
4 ex31-1.htm EX-31.1 21143
5 ex31-2.htm EX-31.2 21293
6 ex32-1.htm EX-32.1 7742
7 ex32-2.htm EX-32.2 7794
  Complete submission text file 0001493152-24-030663.txt   6068598

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE xtnt-20240630.xsd EX-101.SCH 45280
9 XBRL CALCULATION FILE xtnt-20240630_cal.xml EX-101.CAL 78011
10 XBRL DEFINITION FILE xtnt-20240630_def.xml EX-101.DEF 178366
11 XBRL LABEL FILE xtnt-20240630_lab.xml EX-101.LAB 387617
12 XBRL PRESENTATION FILE xtnt-20240630_pre.xml EX-101.PRE 327888
92 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 869883
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 241186051
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)